(Q49023618)

English

Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial.

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

0 references

0 references

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Magnesium in Coronaries (MAGIC) Trial Investigators

1

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

360

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

9341

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

1189-1196

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible pharmacological actions of magnesium in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnesium in acute myocardial infarction: overview of available evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations--magnesium and chloride loss in refractory potassium repletion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnesium in acute MI. Timing is critical

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of effect mechanism in the design and interpretation of clinical trials: the role of magnesium in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of magnesium infusion on thrombolytic and non-thrombolytic treated patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits of magnesium in acute myocardial infarction: timing is crucial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnesium deficiency and myocardial infarct size in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous magnesium in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnesium substitution in acute ischaemic heart syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of magnesium sulfate in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of acetylsalicylic acid, dipyridamole, and hydrocortisone on epinephrine-induced myocardial injury in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum magnesium and potassium in acute myocardial infarction: relationship to existing beta-blockade and infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911278-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(02)11278-5

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/12401244

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49023618&oldid=2050176139"